Machine Learning and Artificial Intelligence Within Pediatric Autoimmune Diseases: Applications, Challenges, Future Perspective Publisher Pubmed



P Sadeghi PARNIYAN ; H Karimi HANIE ; A Lavafian ATIYE ; R Rashedi RONAK ; N Samieefar NOOSHA ; S Shafiekhani SADJAD ; N Rezaei NIMA
Source: Expert Review of Clinical Immunology Published:2024

Abstract

Introduction: Autoimmune disorders affect 4.5% to 9.4% of children, significantly reducing their quality of life. The diagnosis and prognosis of autoimmune diseases are uncertain because of the variety of onset and development. Machine learning can identify clinically relevant patterns from vast amounts of data. Hence, its introduction has been beneficial in the diagnosis and management of patients. Areas covered: This narrative review was conducted through searching various electronic databases, including PubMed, Scopus, and Web of Science. This study thoroughly explores the current knowledge and identifies the remaining gaps in the applications of machine learning specifically in the context of pediatric autoimmune and related diseases. Expert opinion: Machine learning algorithms have the potential to completely change how pediatric autoimmune disorders are identified, treated, and managed. Machine learning can assist physicians in making more precise and fast judgments, identifying new biomarkers and therapeutic targets, and personalizing treatment strategies for each patient by utilizing massive datasets and powerful analytics. © 2024 Elsevier B.V., All rights reserved.